These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 36125128)
1. LATS1/2 control TGFB-directed epithelial-to-mesenchymal transition in the murine dorsal cranial neuroepithelium through YAP regulation. Martínez Traverso IM; Steimle JD; Zhao X; Wang J; Martin JF Development; 2022 Sep; 149(18):. PubMed ID: 36125128 [TBL] [Abstract][Full Text] [Related]
2. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis. Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis. Mohad V; Lungova V; Verheyden J; Thibeault SL Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576 [TBL] [Abstract][Full Text] [Related]
4. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557 [TBL] [Abstract][Full Text] [Related]
5. Yap and Taz play a crucial role in neural crest-derived craniofacial development. Wang J; Xiao Y; Hsu CW; Martinez-Traverso IM; Zhang M; Bai Y; Ishii M; Maxson RE; Olson EN; Dickinson ME; Wythe JD; Martin JF Development; 2016 Feb; 143(3):504-15. PubMed ID: 26718006 [TBL] [Abstract][Full Text] [Related]
6. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2. Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470 [TBL] [Abstract][Full Text] [Related]
7. Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774 [TBL] [Abstract][Full Text] [Related]
8. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1. Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213 [TBL] [Abstract][Full Text] [Related]
9. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443 [TBL] [Abstract][Full Text] [Related]
10. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy. Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439 [TBL] [Abstract][Full Text] [Related]
11. Nantie LB; Young RE; Paltzer WG; Zhang Y; Johnson RL; Verheyden JM; Sun X Development; 2018 Nov; 145(21):. PubMed ID: 30305289 [TBL] [Abstract][Full Text] [Related]
12. St-Jean G; Tsoi M; Abedini A; Levasseur A; Rico C; Morin M; Djordjevic B; Miinalainen I; Kaarteenaho R; Paquet M; Gévry N; Boyer A; Vanderhyden B; Boerboom D Development; 2019 Oct; 146(20):. PubMed ID: 31575647 [TBL] [Abstract][Full Text] [Related]
13. Li L; Dong L; Wang Y; Zhang X; Yan J Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453 [TBL] [Abstract][Full Text] [Related]
14. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling. Mana-Capelli S; McCollum D J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M; Wang M; Xu S; Guo X; Jiang J Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204 [TBL] [Abstract][Full Text] [Related]
16. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway. Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995 [TBL] [Abstract][Full Text] [Related]
17. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate. Abou Nader N; Ménard A; Levasseur A; St-Jean G; Boerboom D; Zamberlam G; Boyer A Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362374 [TBL] [Abstract][Full Text] [Related]
18. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386 [TBL] [Abstract][Full Text] [Related]
20. Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development. Xiao Y; Hill MC; Zhang M; Martin TJ; Morikawa Y; Wang S; Moise AR; Wythe JD; Martin JF Dev Cell; 2018 Apr; 45(2):153-169.e6. PubMed ID: 29689192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]